openPR Logo
Press release

Leading Innovative Biomedical Measurement Companies Announce Merger

07-07-2011 09:03 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Scisense Inc.

London, ON (July 1, 2011) Transonic Systems Inc. of Ithaca, USA and Scisense Inc. of London, Canada announced today their merger. Scisense manufactures advanced products for blood pressure and cardiac pressure volume assessment, while Transonic is an industry leader in biomedical flow measurement technologies and applications.
The newly formed Transonic-Scisense entity combines two biomedical research innovators, both with strong roots in academia. Their combined expertise will pioneer fully-integrated measurement solutions for the heart and cardiovascular research, clinical diagnostic and cardiovascular surgical markets. The companies’ products are sold and serviced worldwide from local offices in USA, Canada, Europe, Taiwan and Japan.
Moreover, the unique synergies between the two companies will provide:
· Top-rated, proven cardiovascular solutions recognized by scientific researchers for their versatility and comprehensiveness;
· A broad, unified platform of global research solutions for universities, contract researchers and pharmaceutical companies;
· A world-class service and support organization benefiting from the best-practices and infrastructure investments of both companies;
· A stronger pre-clinical and clinical research market presence, including an expanded international footprint;
· Larger revenue streams that will allow continued investment towards innovation.
Cornelis Drost, founder and CEO of Transonic Systems comments, “We are most excited about joining forces with Scisense. Together we will be able to provide our customers with a more comprehensive hemodynamic profile for their measurement armamentaria. We also look forward with anticipation the future innovations that this merger will enable.”
“With this merger we are now able to offer our customers complete and exceptional cardiovascular solutions,” notes Blair Poetschke, president & CEO of Scisense. “It will also enhance our ability to develop revolutionary products in the near future that will further strengthen our global position.”

About Transonic Systems Inc.
R&D Scientist and Engineer Cornelis J. Drost founded Transonic Systems Inc in 1983 after inventing the transit time ultrasound flowmeter for vascular applications -the first ever to measure volume flow in blood vessels- while working as a Senior Research Scientist at Cornell University in Ithaca NY. Transonic quickly became the “Gold Standard” in cardiovascular research, then in surgical applications worldwide. As the company progressed, new flow measurement innovations were added in fields such as Hemodialysis, Critical Care, Surgery, ECMO, and Ventricular Assist Devices, and Transonic has now grown to become recognized as a solutions innovator and applications specialist for all biomedical flow measurement challenges. In addition to its ultrasound transit-time and indicator dilution flow measurements, Transonic offers Laser Doppler Meters for Perfusion Monitoring, and a full range of in implantable biotelemetry measurement solutions via its sister company, Endosomatic Systems, Inc.

Media Contacts:
Blair Poetschke, Scisense Inc.
519-680-7677
www.scisense.com
Miriam Tenorio, Transonic Systems Inc.
607-257-5300
www.transonic.com

About Scisense Inc.
Scisense Inc. specializes in micro-sensing technologies for use in preclinical research. Products include high-fidelity pressure sensors used to measure blood pressure, pressure-volume catheters, and catheters for electrophysiology applications. The company’s head office and manufacturing facilities are located in London, Ontario, Canada. Since its incorporation in 2002, Scisense has focused on contributing to the advancement of research into cardiac disease and has established itself as a technology leader. The company employs an expert staff of engineers and scientists, and proudly supports an extensive network of customers at universities, pharmaceutical companies and contract research organizations throughout the world.

3397 White Oak, Rd. Unit #3
London, Ontario
N6E3A1
Canada
Tel: 519.680.7677
Fax:519.680.7718

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leading Innovative Biomedical Measurement Companies Announce Merger here

News-ID: 182482 • Views:

More Releases from Scisense Inc.

Hands-on Workshop Clinic to Assess Cardiac Function
Studying Pressure Volume Loops Using Large-Animal Models: New Insights, Latest Advancements in PV Loop Technology, and Hands-on Experience FOR IMMEDIATE RELEASE April 25, 2011 – A prime focus of this full day workshop will be to analyze quantitative lusitropic and inotropic responses to vasoactive drugs administered to the animal to purposely alter preload, afterload, heart rate and contractility. Attendees will get first-hand experience with surgical equipment, Scisense ADVantageTM pressure-volume system and catheter,
Science of Cardiac Function Assessment using Pressure Volume Loops Web Seminar
FOR IMMEDIATE RELEASE March 21, 2011 - Scisense Inc. hosts Dr. Richard Klabunde, author of “Cardiovascular Physiology Concepts”, to explain the significance of pressure and volume changes during the cardiac cycle on cardiovascular function, covering relationships such as ESPVR, PRSW, and EDPVR. Real-time left ventricular (LV) pressure-volume loops provide a load independent framework for understanding cardiac mechanics in a manner which electrophysiology and dp/dt analysis cannot. Such loops can be generated by
Science of Cardiac Function Assessment using Pressure Volume Loops Web Seminar
Science of Cardiac Function Assessment using Pressure Volume Loops Web Seminar
Real-time left ventricular (LV) pressure-volume loops provide a load independent framework for understanding cardiac mechanics in a manner which electrophysiology and dp/dt analysis cannot. Such loops can be generated by real time measurement of pressure and volume within the left ventricle. Many physiologically relevant hemodynamic parameters such as stroke volume, cardiac output, ejection fraction, myocardial contractility, etc. can be determined from these loops. Dr. Richard Klabunde will explain the pressure

All 4 Releases


More Releases for Transonic

Perfusion Systems Market to Witness an Outstanding Growth By 2027 | Top Key Play …
According to a new market research study titled "Perfusion Systems Market - Global Analysis and Forecasts by Type, Component", the global perfusion systems market is expected to reach US$ 1,442.28 Mn in 2027 from US$ 1,044.75 Mn in 2018. The market is estimated to grow with a CAGR of 3.8% from 2019-2027. The report highlights the trends prevalent in the global perfusion systems market and the factors driving the market
New 1:6 model for AMES Unitary Plant transonic high speed tests
As part of a thorough review of the aircraft AW 609 behaviour, Leonardo Helicopter Division has performed a high speed wind tunnel test campaign at NASA Ames Unitary Plan 11 by 11 foot transonic wind tunnel. After a thorough assessment, the NASA AMES Unitary Plant 11’ by 11’ Transonic Wind Tunnel has been selected to obtain an accurate characterization of the aircraft in full scale conditions up to the highest
Global Left Ventricular Assist Device Market 2018 By Key Players:- Thoratec, Ter …
Market Research Store Exposed a new deep Industry research report focuses on Left Ventricular Assist Device Market, delivers detailed analysis of market and future prospects of Left Ventricular Assist Device market. The critical and significant data in the study makes the research a very important tool for experts, analysts and managers to get ready-to-access analysis by the industry professionals. The Left Ventricular Assist Device Market report provides the complete analysis
Professional Survey Of Global Left Ventricular Assist Device (LVAD) Market 2018 …
Researchmoz added Most up-to-date research on "Global Left Ventricular Assist Device (LVAD) Market Professional Survey Report 2018" to its huge collection of research reports. This report studies Left Ventricular Assist Device (LVAD) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global
Mar 06, 2018: Blood Flow Measurement Device Market Manufacturers Getinge Group, …
QY Research Store Recently added detailed market study on the "Global Blood Flow Measurement Device Market Research Report 2018-2025" which provides an outlook of current market value of Blood Flow Measurement Device Market as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% in Blood Flow Measurement Device Market by the end of 2025. The report on the global Blood Flow Measurement Device market
Organ Transplantation Market Status & Forecast 2027 by Players: Transonic, Trans …
Organ Transplantation Market information by types (kidney, liver) products, commercialized products (Zenapax, Prograf, Cellcept, Myfortic, Neoral), End User - Forecast to 2027 Market Research Future adds new report of “Global Organ Transplantation Market Research Report - Forecast to 2027” it contains Company information, geographical data and Table of Content Organ transplantation is an effective treatment for end-stage organ failure and is extensively practiced around the world. The access of patients to organ